RESUMEN
Eastern equine encephalitis virus (EEEV) causes sporadic epidemics of human and equine disease in North America, but South American strains have seldom been associated with human neurologic disease or mortality, despite serological evidence of infection. In mice, most North American and South American strains of EEEV produce neurologic disease that resembles that associated with human and equine infections. We identified a South American strain that is unable to replicate efficiently in the brain or cause fatal disease in mice yet produces 10-fold higher viremia than virulent EEEV strains. The avirulent South American strain was also sensitive to human interferon (IFN)-alpha, -beta, and -gamma, like most South American strains, in contrast to North American strains that were highly resistant. To identify genes associated with IFN sensitivity and virulence, infectious cDNA clones of a virulent North American strain and the avirulent South American strain were constructed. Two reciprocal chimeric viruses containing swapped structural and nonstructural protein gene regions of the North American and South American strains were also constructed and found to replicate efficiently in vitro. Both chimeras produced fatal disease in mice, similar to that caused by the virulent North American strain. Both chimeric viruses also exhibited intermediate sensitivity to human IFN-alpha, -beta, and -gamma compared to that of the North American and South American strains. Virulence 50% lethal dose assays and serial sacrifice experiments further demonstrated that both structural and nonstructural proteins are important contributors to neurovirulence and viral tissue tropism. Together, the results of this study emphasize the complex and important influences of structural and nonstructural protein gene regions on EEEV virulence.
Asunto(s)
Virus de la Encefalitis Equina del Este/inmunología , Virus de la Encefalitis Equina del Este/patogenicidad , Interferones/inmunología , Proteínas no Estructurales Virales/inmunología , Proteínas no Estructurales Virales/fisiología , Proteínas Estructurales Virales/inmunología , Proteínas Estructurales Virales/fisiología , Animales , Virus de la Encefalitis Equina del Este/genética , Virus de la Encefalitis Equina del Este/crecimiento & desarrollo , Encefalomielitis Equina/virología , Dosificación Letal Mediana , Ratones , Análisis de Supervivencia , Ensayo de Placa Viral , Viremia , VirulenciaRESUMEN
Determining the dose of an arbovirus transmitted by a mosquito is important to design transmission and pathogenesis studies simulating natural infection. Several different artificial infection and transmission methods used to assess vector competence and to estimate the dose injected during mosquito feeding have not been fully evaluated to determine whether they accurately reflect natural transmission. Additionally, it is not known whether different mosquito vectors transmit similar amounts of a given virus. Therefore, we compared three traditional artificial transmission methods using Venezuelan equine encephalitis virus (VEEV) and Aedes albopictus and Ochlerotatus taeniorhynchus mosquitoes. Both the mosquito species and the infection route used affected the amount of virus detected in the saliva after a 10-day extrinsic incubation period. Median titers of virus detected in saliva of Ae. albopictus and Oc. taeniorhynchus mosquitoes ranged from 0.2 to 1.1 log(10) (mean 0.7-1.4 log(10)) and 0.2 to 3.2 log(10) (mean 1.0-3.6 log(10)) plaque-forming units, respectively. The results of this study will aid in the design of transmission and pathogenesis studies involving arboviruses.
Asunto(s)
Culicidae/virología , Virus de la Encefalitis Equina Venezolana/aislamiento & purificación , Encefalomielitis Equina Venezolana/transmisión , Saliva/virología , Aedes/virología , Alimentación Animal , Animales , Femenino , Enfermedades de los Caballos/virología , Caballos , Humanos , Ratones , Ochlerotatus/virología , Viremia/diagnósticoRESUMEN
Venezuelan equine encephalitis virus (VEEV) is an emerging pathogen of equids and humans, but infection of its rodent reservoir hosts has received little study. To determine whether responses to infection vary among geographic populations, we inoculated 3 populations of cotton rats with 2 enzootic VEEV strains (Co97-0054 [enzootic ID subtype] and 68U201 [enzootic IE subtype]). The 3 populations were offspring from wild-caught cotton rats collected in a VEE-enzootic area of south Florida, USA; wild-caught cotton rats from a non-VEE-enzootic area of Texas, USA; and commercially available (Harlan) colony-reared cotton rats from a non-VEE-enzootic region. Although each population had similar early viremia titers, no detectable disease developed in the VEE-sympatric Florida animals, but severe disease and death affected the Texas and Harlan animals. Our findings suggest that the geographic origins of cotton rats are important determinants of the outcome of VEE infection and reservoir potential of these rodents.
Asunto(s)
Virus de la Encefalitis Equina Venezolana/crecimiento & desarrollo , Encefalomielitis Equina Venezolana/veterinaria , Encefalomielitis Equina Venezolana/virología , Enfermedades de los Roedores/virología , Sigmodontinae/virología , Animales , Reservorios de Enfermedades/virología , Encefalomielitis Equina Venezolana/epidemiología , Encefalomielitis Equina Venezolana/inmunología , Femenino , Florida/epidemiología , Masculino , Ratas , Enfermedades de los Roedores/epidemiología , Enfermedades de los Roedores/inmunología , Sigmodontinae/inmunología , Texas/epidemiología , Viremia/epidemiología , Viremia/inmunología , Viremia/virologíaRESUMEN
Due to the lack of a rapid, simple, and inexpensive assay for detecting alphavirus infections, we combined a reverse transcription-PCR with an enzyme-linked immunosorbent assay (RT-PCR-ELISA) to identify human pathogenic alphaviruses that are endemic in the New World. By combining the sensitivity of PCR, the detection simplicity of ELISA, and the specificities of DNA probes, this method rapidly detected and differentiated closely related species and subtypes of several medically important alphaviruses. After an amplification using RT-PCR with primers targeting conserved sequences in the nonstructural protein 1 gene, sequence-specific, biotin-labeled probes targeted against Venezuelan, eastern, and western equine encephalitis or Mayaro virus genes were used for the detection of amplicons using ELISA. The assay is simple, fast, and easy to perform in an ordinary diagnostic laboratory or clinical setting. Nucleic acid derived from cell cultures infected with several alphaviruses, clinical specimens, and mosquito pools as well as frozen and paraffin-embedded animal tissues were detected and identified within 6 to 7 h in a sensitive and specific manner.
Asunto(s)
Infecciones por Alphavirus/diagnóstico , Ensayo de Inmunoadsorción Enzimática/métodos , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Reacciones Cruzadas , Virus de la Encefalitis Equina Venezolana/clasificación , Humanos , Sensibilidad y EspecificidadRESUMEN
Enzootic strains of Venezuelan equine encephalitis virus (VEEV) circulate in forested habitats of Mexico, Central, and South America, and spiny rats (Proechimys spp.) are believed to be the principal reservoir hosts in several foci. To better understand the host-pathogen interactions and resistance to disease characteristic of many reservoir hosts, we performed experimental infections of F1 progeny from Proechimys chrysaeolus collected at a Colombian enzootic VEEV focus using sympatric and allopatric virus strains. All animals became viremic with a mean peak titer of 3.3 log10 PFU/mL, and all seroconverted with antibody titers from 1:20 to 1:640, which persisted up to 15 months. No signs of disease were observed, including after intracerebral injections. The lack of detectable disease and limited histopathologic lesions in these animals contrast dramatically with the severe disease and histopathologic findings observed in other laboratory rodents and humans, and support their role as reservoir hosts with a long-term coevolutionary relationship to VEEV.
Asunto(s)
Reservorios de Enfermedades , Virus de la Encefalitis Equina Venezolana/aislamiento & purificación , Roedores/virología , Animales , Anticuerpos Antivirales/sangre , Evolución Biológica , Colombia , Virus de la Encefalitis Equina Venezolana/clasificación , Virus de la Encefalitis Equina Venezolana/patogenicidad , Ganglios Linfáticos/ultraestructura , Ganglios Linfáticos/virología , Viremia , Replicación ViralRESUMEN
Eastern equine encephalitis virus (EEEV) causes human encephalitis in North America (NA), but in South America (SA) it has rarely been associated with human disease, suggesting that SA strains are less virulent. To evaluate the hypothesis that this virulence difference is due to a greater ability of NA strains to evade innate immunity, we compared replication of NA and SA strains in Vero cells pretreated with interferon (IFN). Human IFN-alpha, -beta, and -gamma generally exhibited less effect on replication of NA than SA strains, supporting this hypothesis. In the murine model, no consistent difference in IFN induction was observed between NA and SA strains. After infection with most EEEV strains, higher viremia levels and shorter survival times were observed in mice deficient in IFN-alpha/beta receptors than in wild-type mice, suggesting that IFN-alpha/beta is important in controlling replication. In contrast, IFN-gamma receptor-deficient mice infected with NA and SA strains had similar viremia levels and mortality rates to those of wild-type mice, suggesting that IFN-gamma does not play a major role in murine protection. Mice pretreated with poly(I-C), a nonspecific IFN inducer, exhibited dose-dependent protection against fatal eastern equine encephalitis, further evidence that IFN is important in controlling disease. Overall, our in vivo results did not support the hypothesis that NA strains are more virulent in humans due to their greater ability to counteract the IFN response. However, further studies using a better model of human disease are needed to confirm the results of differential human IFN sensitivity obtained in our in vitro experiments.
Asunto(s)
Virus de la Encefalitis Equina del Este/inmunología , Encefalomielitis Equina/inmunología , Interferones/fisiología , Animales , Antivirales/farmacología , Chlorocebus aethiops , Virus de la Encefalitis Equina del Este/patogenicidad , Humanos , Interferón-alfa/farmacología , Interferón beta/farmacología , Interferón gamma/farmacología , Interferones/farmacología , Ratones , Ratones Noqueados , Receptores de Interferón/genética , Proteínas Recombinantes , Células Vero , Replicación Viral/inmunologíaRESUMEN
The peptide binding C-terminal portion of heat shock protein (HSP)70 (aa 359-610) stimulates human monocytes to produce IL-12, TNF-alpha, NO, and C-C chemokines. The N-terminal, ATPase portion (HSP70(1-358)) failed to stimulate any of these cytokines or chemokines. Both native and the truncated HSP70(359-610) stimulation of chemokine production is mediated by the CD40 costimulatory molecule. Maturation of dendritic cells was induced by stimulation with native HSP70, was not seen with the N-terminal HSP70(1-358), but was enhanced with HSP70(359-610), as demonstrated by up-regulation of CD83, CCR7, CD86, CD80, and HLA class II. In vivo studies in macaques showed that immunization with HSP70(359-610) enhances the production of IL-12 and RANTES. Immunization with peptide-bound HSP70(359-610) in mice induced higher serum IgG2a and IgG3 Abs than the native HSP70-bound peptide. This study suggests that the C-terminal, peptide-binding portion of HSP70 is responsible for stimulating Th1-polarizing cytokines, C-C chemokines, and an adjuvant function.
Asunto(s)
Adyuvantes Inmunológicos/fisiología , Quimiocinas CC/biosíntesis , Citocinas/biosíntesis , Células Dendríticas/citología , Proteínas HSP70 de Choque Térmico/fisiología , Fragmentos de Péptidos/fisiología , Células TH1/metabolismo , Adenosina Trifosfatasas/farmacología , Adyuvantes Inmunológicos/administración & dosificación , Adyuvantes Inmunológicos/metabolismo , Animales , Anticuerpos Antibacterianos/biosíntesis , Proteínas Bacterianas , Diferenciación Celular/inmunología , Línea Celular , Quimiocina CCL5/biosíntesis , Células Dendríticas/inmunología , Células Dendríticas/metabolismo , Proteínas HSP70 de Choque Térmico/administración & dosificación , Proteínas HSP70 de Choque Térmico/inmunología , Proteínas HSP70 de Choque Térmico/metabolismo , Humanos , Inmunoglobulina G/biosíntesis , Inmunofenotipificación , Interleucina-12/biosíntesis , Macaca mulatta , Ratones , Ratones Endogámicos C57BL , Mycobacterium tuberculosis/inmunología , Óxido Nítrico/biosíntesis , Fragmentos de Péptidos/administración & dosificación , Fragmentos de Péptidos/inmunología , Fragmentos de Péptidos/metabolismo , Unión Proteica/inmunología , Receptores CCR5/administración & dosificación , Receptores CCR5/inmunología , Receptores CCR5/metabolismo , Células TH1/inmunología , Células TH1/microbiología , Factor de Necrosis Tumoral alfa/biosíntesis , VacunaciónRESUMEN
To assess the role of horses as amplification hosts during the 1993 and 1996 Mexican Venezuelan equine encephalitis (VEE) epizootics, we subcutaneously infected 10 horses by using four different equine isolates. Most horses showed little or no disease and low or nonexistent viremia. Neurologic disease developed in only 1 horse, and brain histopathologic examination showed meningeal lymphocytic infiltration, perivascular cuffing, and focal encephalitis. Three animals showed mild meningoencephalitis without clinical disease. Viral RNA was detected in the brain of several animals 12-14 days after infection. These data suggest that the duration and scope of the recent Mexican epizootics were limited by lack of equine amplification characteristic of previous, more extensive VEE outbreaks. The Mexican epizootics may have resulted from the circulation of a more equine-neurotropic, subtype IE virus strain or from increased transmission to horses due to amplification by other vertebrate hosts or transmission by more competent mosquito vectors.
Asunto(s)
Virus de la Encefalitis Equina Venezolana/aislamiento & purificación , Virus de la Encefalitis Equina Venezolana/patogenicidad , Encefalomielitis Equina Venezolana/veterinaria , Enfermedades de los Caballos/virología , Animales , Encéfalo/virología , Enfermedades Transmisibles Emergentes/genética , Virus de la Encefalitis Equina Venezolana/genética , Encefalomielitis Equina Venezolana/epidemiología , Encefalomielitis Equina Venezolana/virología , Amplificación de Genes , Histocitoquímica , Enfermedades de los Caballos/sangre , Enfermedades de los Caballos/epidemiología , Caballos , Recuento de Leucocitos , México/epidemiología , Ratones , Recuento de Plaquetas , ARN Viral/aislamiento & purificación , Temperatura , VirulenciaRESUMEN
Venezuelan equine encephalitis virus (VEEV) is a reemerging pathogen and a continuing threat to humans and equines in the Americas. Identification of the genetic determinants that enable epizootic VEEV strains to arise and exploit equines as amplification hosts to cause widespread human disease is pivotal to understanding VEE emergence. The sensitivity to murine alpha/beta interferon-mediated antiviral activity was previously correlated to the epizootic phenotype of several VEEV strains. Infectious cDNA clones were generated from an epizootic subtype IC VEEV strain (SH3) isolated during the 1992 Venezuelan outbreak and a closely related enzootic, sympatric subtype ID strain (ZPC738). These VEEV strains had low-cell-culture-passage histories and differed by only 12 amino acids in the nonstructural and structural proteins. Rescued viruses showed similar growth kinetics to their parent viruses in several cell lines, and murine infections resulted in comparable viremia and disease. Unlike what was found in other studies of epizootic and enzootic VEEV strains, the sensitivities to murine alpha/beta interferon did not differ appreciably between these epizootic versus enzootic strains, calling into question the reliability of interferon sensitivity as a marker of epizootic potential.
Asunto(s)
Antivirales/farmacología , ADN Complementario/genética , Virus de la Encefalitis Equina Venezolana/patogenicidad , Interferón-alfa/farmacología , Interferón beta/farmacología , Animales , Línea Celular , Chlorocebus aethiops , Clonación Molecular , Enfermedades Transmisibles Emergentes/virología , Cricetinae , Virus de la Encefalitis Equina Venezolana/efectos de los fármacos , Virus de la Encefalitis Equina Venezolana/genética , Virus de la Encefalitis Equina Venezolana/fisiología , Encefalomielitis Equina Venezolana/virología , Humanos , Ratones , Células Vero , Virulencia , Replicación ViralRESUMEN
Serological diagnosis of West Nile virus (WNV) infection is complicated by extensive antigenic cross-reactivity with other closely related flaviviruses, such as St. Louis encephalitis virus. Here we describe a recombinant, bacterially expressed antigen equivalent to structural domain III of the WNV envelope protein that has allowed clear discrimination of antibody responses to WNV from those against other related flaviviruses in indirect enzyme-linked immunosorbent assays using standardized control antisera and field-collected samples.
Asunto(s)
Anticuerpos Antivirales/sangre , Antígenos Virales/inmunología , Fiebre del Nilo Occidental/diagnóstico , Virus del Nilo Occidental/inmunología , Animales , Ensayo de Inmunoadsorción Enzimática , Humanos , Inmunoglobulina G/sangre , Ratones , Subunidades de Proteína , Conejos , Proteínas Recombinantes/inmunología , Pruebas SerológicasRESUMEN
West Nile virus (WNV) antibodies were detected in horses from five Mexican states, and WNV was isolated from a Common Raven in the state of Tabasco. Phylogenetic studies indicate that this isolate, the first from Mexico, is related to strains from the central United States but has a relatively high degree of sequence divergence.